PIC
BCYC

Portland Investment Counsel’s Bicycle Therapeutics BCYC Stock Holding History

Portland Investment Counsel’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.6K Hold
15,000
– – 0.02% 55
2025
Q4 		$106K Hold
15,000
– – 0.03% 51
2025
Q3 		$116K Hold
15,000
– – 0.03% 51
2025
Q2 		$109K Hold
15,000
– – 0.03% 45
2025
Q1 		$127K Buy
+15,000
New +$177K 0.04% 46

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Portland Investment Counsel's BCYC Position: Q1 2026 in Review

Portland Investment Counsel held its Bicycle Therapeutics (BCYC) position steady in Q1 2026 at 15,000 shares worth $69.6K. The position accounts for 0.02% of the portfolio, ranked #55.

Portland Investment Counsel first reported a position in BCYC in Q1 2025 and has held it in 5 quarters since. The position peaked at $127K in Q1 2025. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Portland Investment Counsel held 15,000 shares of Bicycle Therapeutics worth $69.6K as of Q1 2026.
  • Portland Investment Counsel left its Bicycle Therapeutics share count unchanged in Q1 2026.
  • Bicycle Therapeutics made up 0.02% of Portland Investment Counsel's portfolio in Q1 2026, its #55 holding.
  • Portland Investment Counsel first reported a position in Bicycle Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Portland Investment Counsel's Bicycle Therapeutics position peaked at $127K in Q1 2025.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Portland Investment Counsel's 13F filing for Q1 2026, filed 14 May 2026.